The association of polyunsaturated fatty acids and asthma: a cross-sectional study

Gangtie Liu1, Hengbo Ye2, Qian Cheng2

  • 1Department of Pediatrics, Taian Maternal and Child Healthcare Hospital, No.386 Longtan Road, Taian, 271000, Shandong Province, People's Republic of China. tafyenk@outlook.com.

Insights

Higher intake of polyunsaturated fatty acids (PUFAs), specifically docosahexaenoic acid, is linked to reduced childhood asthma risk. This protective effect is more pronounced in males and children exposed to maternal smoking during pregnancy.

Area of Science:

  • Nutritional Epidemiology
  • Pediatric Respiratory Health
  • Omega-3 Fatty Acids Research

Background:

  • Asthma is a significant global health concern in children.
  • Dietary factors, including polyunsaturated fatty acids (PUFAs), are increasingly investigated for their role in asthma development.
  • Understanding the PUFA-asthma link can inform preventive strategies.

Purpose of the Study:

  • To investigate the association between dietary intake of various PUFAs and the prevalence of asthma in children.
  • To explore potential modifying effects of gender, age, and maternal smoking on this relationship.

Main Methods:

  • Utilized data from 14,727 participants in the US National Health and Nutrition Examination Survey (NHANES) (1999-2018).
  • Employed descriptive analysis and weighted multivariate logistic regression to assess PUFA intake and asthma association.
  • Conducted subgroup analyses based on gender, age, and maternal smoking history.

Main Results:

  • A total of 15.38% of participants had asthma.
  • Dietary intake of docosahexaenoic acid (DHA), total n-3 PUFAs, and eicosapentaenoic acid (EPA) showed a negative association with childhood asthma.
  • Subgroup analysis revealed a stronger negative association between DHA intake and asthma in males, children aged 5-12 years, and those whose mothers smoked during pregnancy.

Conclusions:

  • Dietary intake of DHA is significantly associated with a reduced risk of asthma in children.
  • The protective effect of DHA against childhood asthma is particularly evident in specific subgroups, including males, children aged 5-12 years, and those with a history of maternal smoking during pregnancy.
Abstract

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.7K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.5K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
442
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
353